Jim Simons Logic Bio Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.67 $39,707 - $91,737	-136,922 Reduced 32.62%	282,877 $77,000
Q2 2022 Aug 12, 2022	SELL	$0.35 - $0.74 $13,790 - $29,156	-39,400 Reduced 8.58%	419,799 $147,000
Q1 2022 May 13, 2022	BUY	$0.61 - $2.49 $280,111 - $1.14 Million	459,199 New	459,199 $312,000
Q4 2021 Feb 11, 2022	SELL	$2.2 - $4.53 $103,840 - $213,816	-47,200 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.85 - $5.09 $189,805 - $250,937	-49,300 Reduced 51.09%	47,200 $216,000
Q2 2021 Aug 13, 2021	BUY	$4.03 - $7.57 $388,895 - $730,505	96,500 New	96,500 $428,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.